We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

400 hedge funds and large institutions have $6.44B invested in United Therapeutics in 2017 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 135 increasing their positions, 139 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 32

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

26% more capital invested

Capital invested by funds: $5.13B → $6.44B (+$1.31B)

7% more funds holding

Funds holding: 373 → 400 (+27)

0.49% more ownership

Funds ownership: 100.54% → 101.03% (+0.49%)

3% less repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 139

11% less call options, than puts

Call options by funds: $20.4M | Put options by funds: $23M

Holders
400
Holders Change
+27
Holders Change %
+7.24%
% of All Funds
9.07%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
62
Increased
135
Reduced
139
Closed
32
Calls
$20.4M
Puts
$23M
Net Calls
-$2.55M
Net Calls Change
-$45.6M

Top Buyers

1
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$47.1M
2
WCM
Wedge Capital Management
North Carolina
+$39.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$24.4M
4
Renaissance Technologies
Renaissance Technologies
New York
+$24.1M
5
Fidelity International
Fidelity International
Bermuda
+$20.8M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$43.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.4M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$31.4M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$24.2M
5
State Street
State Street
Massachusetts
-$21.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIA
151
Capital Impact Advisors
Massachusetts
$2.38M – – –
SOMRS
152
State of Michigan Retirement System
Michigan
$2.29M -$102K -800 -5%
DCM
153
Dynamic Capital Management
Jersey
$2.28M +$1.96M +15,440 New
AAMU
154
Amundi Asset Management US
Massachusetts
$2.23M +$1.92M +15,066 New
ARTA
155
A.R.T. Advisors
New York
$2.21M +$1.9M +14,954 New
HA
156
Hays Advisory
Tennessee
$2.19M -$887K -6,975 -32%
Caisse de Depot et Placement du Quebec (CDPQ)
157
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$2.09M -$50.9K -400 -3%
GIBU
158
Gulf International Bank (UK)
United Kingdom
$2.09M – – –
FAF
159
Fjarde Ap-fonden
Sweden
$2.06M +$132K +1,040 +8%
American Century Companies
160
American Century Companies
Missouri
$2.04M -$250K -1,963 -12%
BIP
161
Brandes Investment Partners
California
$2.03M +$1.74M +13,713 New
Nomura Asset Management
162
Nomura Asset Management
Japan
$2M +$1.08M +8,496 +168%
Truist Financial
163
Truist Financial
North Carolina
$1.97M -$25.2K -198 -1%
MERSOM
164
Municipal Employees' Retirement System of Michigan
Michigan
$1.94M – – –
AIP
165
Ameritas Investment Partners
Nebraska
$1.93M -$59.5K -468 -3%
LCM
166
Laurion Capital Management
New York
$1.92M +$178K +1,400 +12%
AAF
167
Andra AP-fonden
Sweden
$1.86M -$394K -3,100 -20%
LMGAM
168
Liberty Mutual Group Asset Management
Massachusetts
$1.85M -$96.5K -759 -6%
NAM
169
NorthCoast Asset Management
Connecticut
$1.84M -$83K -653 -5%
MLICM
170
Metropolitan Life Insurance Company (MetLife)
New York
$1.83M -$3.62M -28,485 -70%
Simplex Trading
171
Simplex Trading
Illinois
$1.83M +$687K +5,405 +78%
Teacher Retirement System of Texas
172
Teacher Retirement System of Texas
Texas
$1.81M +$1.56M +12,247 New
SFM
173
Systematic Financial Management
New Jersey
$1.81M +$133K +1,045 +9%
RC
174
RegentAtlantic Capital
New Jersey
$1.81M -$90.8K -714 -6%
Pacer Advisors
175
Pacer Advisors
Pennsylvania
$1.76M +$602K +4,738 +66%
5 6
7
8 9

UTHR Hedge Fund Activity: Q4 2017 in Review

400 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2017, worth a combined $6.44B — up 26% from $5.13B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new UTHR positions and 32 closed out — a net gain of 30 holders — while 135 added to existing stakes and 139 trimmed.

The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $47.1M. The largest seller was Morgan Stanley, cutting an estimated $43.6M.

  • 400 institutional investors held United Therapeutics (UTHR) as of Q4 2017, up from 373 in Q3 2017.
  • Funds reported $6.44B of United Therapeutics stock for Q4 2017, up 26% quarter-over-quarter.
  • 62 funds opened new United Therapeutics positions in Q4 2017 and 32 closed out, a net change of +30 holders.
  • The largest United Therapeutics buyer in Q4 2017 was Skandinaviska Enskilda Banken (SEB), an estimated $47.1M added.
  • The largest United Therapeutics seller in Q4 2017 was Morgan Stanley, an estimated $43.6M sold.

Based on aggregated 13F filings for Q4 2017.